587 related articles for article (PubMed ID: 23742770)
1. Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores.
Chok KSh; Chan SC; Fung JY; Cheung TT; Chan AC; Fan ST; Lo CM
Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):256-62. PubMed ID: 23742770
[TBL] [Abstract][Full Text] [Related]
2. A high model for end-stage liver disease score should not be considered a contraindication to living donor liver transplantation.
Poon KS; Chen TH; Jeng LB; Yang HR; Li PC; Lee CC; Yeh CC; Lai HC; Su WP; Peng CY; Chen YF; Ho YJ; Tsai PP
Transplant Proc; 2012 Mar; 44(2):316-9. PubMed ID: 22410005
[TBL] [Abstract][Full Text] [Related]
3. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
Chok KS; Fung JY; Chan AC; Dai WC; Sharr WW; Cheung TT; Chan SC; Lo CM
Ann Surg; 2017 Jan; 265(1):173-177. PubMed ID: 28009743
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease.
Lai YH; Duan WD; Yu Q; Ye S; Xiao NJ; Zhang DX; Huang ZQ; Yang ZY; Dong JH
World J Gastroenterol; 2015 May; 21(20):6296-303. PubMed ID: 26034365
[TBL] [Abstract][Full Text] [Related]
5. Survival outcomes in liver transplant recipients with Model for End-stage Liver Disease scores of 40 or higher: a decade-long experience.
Panchal HJ; Durinka JB; Patterson J; Karipineni F; Ashburn S; Siskind E; Ortiz J
HPB (Oxford); 2015 Dec; 17(12):1074-84. PubMed ID: 26373873
[TBL] [Abstract][Full Text] [Related]
6. Which score system can best predict recipient outcomes after living donor liver transplantation?
Chung IS; Park M; Ko JS; Gwak MS; Kim GS; Lee SK
Transplant Proc; 2012 Mar; 44(2):393-5. PubMed ID: 22410025
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation.
Li C; Wen TF; Yan LN; Li B; Yang JY; Xu MQ; Wang WT; Wei YG
Ann Hepatol; 2012; 11(4):471-7. PubMed ID: 22700628
[TBL] [Abstract][Full Text] [Related]
8. Defining long-term outcomes with living donor liver transplantation in North America.
Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
[TBL] [Abstract][Full Text] [Related]
9. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
Selzner M; Kashfi A; Cattral MS; Selzner N; Greig PD; Lilly L; McGilvray ID; Therapondos G; Adcock LE; Ghanekar A; Levy GA; Renner EL; Grant DR
Liver Transpl; 2009 Dec; 15(12):1776-82. PubMed ID: 19938139
[TBL] [Abstract][Full Text] [Related]
10. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
[TBL] [Abstract][Full Text] [Related]
11. Does model for end-stage liver disease score predict the short-term outcome of living donor liver transplantation?
Li C; Wen T; Yan L; Li B; Wang W; Xu M; Yang J; Wei Y
Transplant Proc; 2010 Nov; 42(9):3620-3. PubMed ID: 21094827
[TBL] [Abstract][Full Text] [Related]
12. Impact of MELD score implementation on liver allocation: experience at a Brazilian center.
da Silva Machado AG; de Medeiros Fleck A; Marroni C; Zanotelli ML; Cantisani G; de Mello Brandão AB
Ann Hepatol; 2013; 12(3):440-7. PubMed ID: 23619261
[TBL] [Abstract][Full Text] [Related]
13. The role of Model for End-Stage Liver Disease (MELD) score in predicting outcomes for lower extremity bypass.
Krafcik BM; Farber A; Eslami MH; Kalish JA; Rybin D; Doros G; Shah NK; Siracuse JJ
J Vasc Surg; 2016 Jul; 64(1):124-30. PubMed ID: 26994957
[TBL] [Abstract][Full Text] [Related]
14. Pretransplant Model for End-stage Liver Disease score has no impact on posttransplant survival in living donor liver transplantation.
Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
Transplant Proc; 2012 Mar; 44(2):396-8. PubMed ID: 22410026
[TBL] [Abstract][Full Text] [Related]
15. Live donor liver transplantation in high MELD score recipients.
Selzner M; Kashfi A; Cattral MS; Selzner N; McGilvray ID; Greig PD; Levy GA; Renner EL; Grant DR
Ann Surg; 2010 Jan; 251(1):153-7. PubMed ID: 19858705
[TBL] [Abstract][Full Text] [Related]
16. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
[TBL] [Abstract][Full Text] [Related]
17. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
[TBL] [Abstract][Full Text] [Related]
18. D-MELD as a predictor of early graft mortality in adult-to-adult living-donor liver transplantation.
Ikegami T; Imai D; Wang H; Yoshizumi T; Yamashita Y; Ninomiya M; Iguchi T; Bekki Y; Shirabe K; Maehara Y
Transplantation; 2014 Feb; 97(4):457-62. PubMed ID: 24531822
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Short-Term and Long-Term Outcomes of Living Donor Liver Transplantation for Patients with a High Model for End-Stage Liver Disease Score.
Matoba D; Noda T; Kobayashi S; Sasaki K; Iwagami Y; Yamada D; Tomimaru Y; Takahashi H; Doki Y; Eguchi H
Transplant Proc; 2023 May; 55(4):893-897. PubMed ID: 37120341
[TBL] [Abstract][Full Text] [Related]
20. Application of postoperative Model for End-Stage Liver Disease scoring system for evaluating liver graft function after living donor liver transplantation.
Toshima T; Ikegami T; Kimura K; Harimoto N; Yamashita Y; Yoshizumi T; Soejima Y; Ikeda T; Shirabe K; Maehara Y
Transplant Proc; 2014; 46(1):81-6. PubMed ID: 24507030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
